Connection
Samer Al Hadidi to Survival Analysis
This is a "connection" page, showing publications Samer Al Hadidi has written about Survival Analysis.
|
|
Connection Strength |
|
 |
|
 |
|
0.187 |
|
|
|
-
Al Hadidi S, van Rhee F. Overall Survival Analysis of the Use of Elotuzumab in ELOQUENT-3 Trial. J Clin Oncol. 2023 03 20; 41(9):1788.
Score: 0.187